Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Amgen, 5.5% 7dec2026, GBP
XS0710091140

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy

Senior Unsecured

Issue
Issuer
  • M
    -
    ****
  • S&P
    -
    ****
  • F
    -
    ****
*in foreign currency
Status
Outstanding
Amount
475,000,000 GBP
Placement
***
Early redemption
*** (-)
Country of risk
USA
Current coupon
***%
Price
***%
Yield / Duration
-
Corporate Actions Issuer news
Add issue to Watchlist
{{ watchlistErrorMsg }}
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Request additional prices

Issue information

Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel ...
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
  • Borrower
    Go to the issuer page
    Amgen
  • Full issuer name
    Amgen, Inc.
  • Sector
    corporate
  • Industry
    Healthсare
Volume
  • Amount
    475,000,000 GBP
  • Outstanding face value amount
    475,000,000 GBP
  • USD equivalent
    650,322,500 USD
Nominal
  • Minimum Settlement Amount
    100,000 GBP
  • Outstanding face value
    *** GBP
  • Par amount, integral multiple
    *** GBP
  • Nominal
    1,000 GBP

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** GBP
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms
    ***

Additional information

***

Latest issues

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN
    XS0710091140
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    071009114
  • CFI
    DBFNBR
  • FIGI
    BBG0029K6RQ7
  • WKN
    A1GX0L
  • SEDOL
    B3VY1Y2
  • Ticker
    AMGN 5.5 12/07/26
  • Type of security by CBR
    ***

Ratings



Bond classification

  • Senior Unsecured
  • Registered
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Floating rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Subordinated
  • Sukuk
  • Trace-eligible

Restructuring

***

***

Holders